Retraction: Impact and Cost-effectiveness of Human Papillomavirus Vaccination Campaigns.
Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ.
Cancer Epidemiol Biomarkers Prev. 2021 Jun. 30(6):1283. PMID: 34074734
Research Scientist
Emily Annika Burger
Links
Bibliography
Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis.
Smith MA, Burger EA, Castanon A, de Kok IMCM, Hanley SJB, Rebolj M, Hall MT, Jansen EEL, Killen J, O'Farrell X, Kim JJ, Canfell K.
Prev Med. 2021 10. 151:106623. PMID: 34029578
Cervical screening during the COVID-19 pandemic: optimising recovery strategies.
Castanon A, Rebolj M, Burger EA, de Kok IMCM, Smith MA, Hanley SJB, Carozzi FM, Peacock S, O'Mahony JF.
Lancet Public Health. 2021 07. 6(7):e522-e527. PMID: 33939965
Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.
Burger EA, Jansen EE, Killen J, Kok IM, Smith MA, Sy S, Dunnewind N, G Campos N, Haas JS, Kobrin S, Kamineni A, Canfell K, Kim JJ.
J Med Screen. 2021 06. 28(2):213-216. PMID: 33730899
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.
Kim JJ, Simms KT, Killen J, Smith MA, Burger EA, Sy S, Regan C, Canfell K.
PLoS Med. 2021 03. 18(3):e1003534. PMID: 33705382
Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis.
Portnoy A, Pedersen K, Trogstad L, Hansen BT, Feiring B, Laake I, Smith MA, Sy S, Nygård M, Kim JJ, Burger EA.
Prev Med. 2021 03. 144:106276. PMID: 33678239
Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.
Fogelberg S, Clements MS, Pedersen K, Sy S, Sparén P, Kim JJ, Burger EA.
PLoS One. 2020. 15(9):e0239611. PMID: 32997696
Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis.
Burger EA, de Kok IMCM, Groene E, Killen J, Canfell K, Kulasingam S, Kuntz KM, Matthijsse S, Regan C, Simms KT, Smith MA, Sy S, Alarid-Escudero F, Vaidyanathan V, van Ballegooijen M, Kim JJ.
J Natl Cancer Inst. 2020 09 01. 112(9):955-963. PMID: 31821501
Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries.
Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ.
Int J Cancer. 2021 02 15. 148(4):932-940. PMID: 32706907
Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions.
Simms KT, Yuill S, Killen J, Smith MA, Kulasingam S, de Kok IMCM, van Ballegooijen M, Burger EA, Regan C, Kim JJ, Canfell K.
Gynecol Oncol. 2020 09. 158(3):710-718. PMID: 32723676